396 related articles for article (PubMed ID: 16889838)
1. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
3. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
[TBL] [Abstract][Full Text] [Related]
4. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
Mitra D; Sikder SK; Laurence J
Virology; 1995 Dec; 214(2):512-21. PubMed ID: 8553553
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
[TBL] [Abstract][Full Text] [Related]
7. Activation of the glucocorticoid receptor releases unstimulated PBMCs from an early block in HIV-1 replication.
Wiegers K; Schwarck D; Reimer R; Bohn W
Virology; 2008 May; 375(1):73-84. PubMed ID: 18295813
[TBL] [Abstract][Full Text] [Related]
8. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
Connor RI; Chen BK; Choe S; Landau NR
Virology; 1995 Feb; 206(2):935-44. PubMed ID: 7531918
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
Forget J; Yao XJ; Mercier J; Cohen EA
J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Vpr-induced cell cycle abnormality by quercetin: a novel strategy for searching compounds targeting Vpr.
Shimura M; Zhou Y; Asada Y; Yoshikawa T; Hatake K; Takaku F; Ishizaka Y
Biochem Biophys Res Commun; 1999 Aug; 261(2):308-16. PubMed ID: 10425183
[TBL] [Abstract][Full Text] [Related]
11. Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.
Watanabe N; Nishihara Y; Yamaguchi T; Koito A; Miyoshi H; Kakeya H; Osada H
FEBS Lett; 2006 May; 580(11):2598-602. PubMed ID: 16631749
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy.
Suzuki T; Yamamoto N; Nonaka M; Hashimoto Y; Matsuda G; Takeshima SN; Matsuyama M; Igarashi T; Miura T; Tanaka R; Kato S; Aida Y
Biochem Biophys Res Commun; 2009 Mar; 380(4):838-43. PubMed ID: 19338763
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?
Kino T; Chrousos GP
Ann N Y Acad Sci; 2004 Jun; 1024():153-67. PubMed ID: 15265780
[TBL] [Abstract][Full Text] [Related]
14. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
Philippon V; Matsuda Z; Essex M
J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
[TBL] [Abstract][Full Text] [Related]
15. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages.
Nitahara-Kasahara Y; Kamata M; Yamamoto T; Zhang X; Miyamoto Y; Muneta K; Iijima S; Yoneda Y; Tsunetsugu-Yokota Y; Aida Y
J Virol; 2007 May; 81(10):5284-93. PubMed ID: 17344301
[TBL] [Abstract][Full Text] [Related]
16. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
Iijima S; Nitahara-Kasahara Y; Kimata K; Zhong Zhuang W; Kamata M; Isogai M; Miwa M; Tsunetsugu-Yokota Y; Aida Y
Virology; 2004 Oct; 327(2):249-61. PubMed ID: 15351213
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages.
Muthumani K; Kudchodkar S; Papasavvas E; Montaner LJ; Weiner DB; Ayyavoo V
J Leukoc Biol; 2000 Sep; 68(3):366-72. PubMed ID: 10985253
[TBL] [Abstract][Full Text] [Related]
19. Suppression of HIV-1 transcription and replication by a Vpr mutant.
Sawaya BE; Khalili K; Rappaport J; Serio D; Chen W; Srinivasan A; Amini S
Gene Ther; 1999 May; 6(5):947-50. PubMed ID: 10505122
[TBL] [Abstract][Full Text] [Related]
20. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.
Kootstra NA; Schuitemaker H
Virology; 1999 Jan; 253(2):170-80. PubMed ID: 9918876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
